Mechanisms of regulation of LRH-1, Nanog and SF-1 by DAX-1
DAX-1对LRH-1、Nanog和SF-1的调节机制
基本信息
- 批准号:8029560
- 负责人:
- 金额:$ 33.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-12-10 至 2012-11-30
- 项目状态:已结题
- 来源:
- 关键词:Adrenal GlandsAdrenal gland hypofunctionAffectApplications GrantsBile AcidsBindingBiochemicalBiological AssayBudgetsCellsCharacteristicsCholesterol HomeostasisCodeCollaborationsComplementComplexCongenital Adrenal HypoplasiaConsultDNADNA Binding DomainDNA DamageDefectDevelopmentDevelopmental ProcessDiseaseEducational process of instructingEmbryonic DevelopmentEndocrineEndocrine SyndromeEndocrine System DiseasesEndocrine systemExperimental DesignsFamilyFemaleFibrinogenFoundationsFundingGenderGene TargetingGenesGeneticGenetic TranscriptionGoalsGrantHealthHollyHomologous GeneHormonesHumanHuman ResourcesHypothalamic structureInfertilityInheritedLearningLengthLettersLifeLinkLiverMaintenanceMalignant NeoplasmsMalignant neoplasm of testisMedicalMental HealthMetabolic DiseasesMethodsMolecular BiologyMutationNR0B1 geneNamesNeurosecretory SystemsNuclear Orphan ReceptorNuclear ReceptorsOrphanOvaryParticipantPathway interactionsPharmaceutical PreparationsPhenotypePhysiologicalPituitary GlandPreparationPrincipal InvestigatorProcessProtein BindingProteinsProtocols documentationRegulationRelative (related person)ResearchResolutionRoleScreening procedureStructural ModelsStructureSyndromeSystemTestingTestisTherapeutic InterventionTimeTissuesTranscriptional ActivationUnited States National Institutes of HealthUpdateWorkX ChromosomeX-Ray Crystallographybasecholesterol biosynthesisderepressiondesigndosageembryonic stem cellexperiencegene repressionhomeodomainin vitro Assaymembermolecular pathologymutantnovelpluripotencyprogramsprotein complexreceptorresearch studysexsteroid hormone biosynthesissuccessthree dimensional structuretranscription factor
项目摘要
DESCRIPTION (provided by applicant): Nuclear receptors program many endocrine processes essential for health and life. Among the most enigmatic are those receptors, which are critically important but have unknown regulating hormones, such as DAX-1, LRH-1 and SF-1. These are the targets of this proposal. Medical disorders teach us about the interplay of these receptors in the endocrine system without telling us their mechanisms. The DAX-1 gene codes an unusual nuclear receptor lacking a DNA interaction domain. Yet it controls the activity of many target genes in many tissues. Mutations in DAX-1 affect embryonic stem cell progression, development of the adrenal and pituitary glands, the hypothalamus and the ovaries or testes leading to severe endocrine disorders. The receptors LRH-1 and SF-1 are critical in developmental processes, and their constitutive activation is muted by DAX-1. These three nuclear receptors and transcription factors are called orphans because their controlling hormones, if they exist, have not been identified. The most basic details of the mechanisms of regulation of these related nuclear receptors are not known.
The goal of this proposal is to understand the principles and atomic level details of the mechanisms of regulation of LRH-1 and SF-1 by DAX-1. Since it halts transcriptional activation, DAX-1 may be classed as a co-repressor with unknown hormone. Because regulation by DAX-1 depends on the associations of these proteins we will analyze, at atomic resolution, the binding interactions of DAX-1 with LRH-1 and SF-1. DAX-1 protein, which has never been prepared in a functionally active state for either biochemical or structural studies, will be isolated and crystallized with LRH-1 and SF-1 so that three-dimensional structures of the assemblies may be analyzed. Functional studies guided by the structural models will carried out in cells to reveal the mechanisms of action of these receptors. This information will be the foundation for understanding the molecular pathology of numerous human endocrine syndromes and suggest pathways for therapeutic intervention.
The nuclear receptors we are studying are associated with many disease processes, including cancer, infertility, genetic metabolic diseases, and mental health defects. Learning the mechanisms of action of these receptors, and what goes wrong in the diseases, will help suggest pathways for design of new drug treatments for these conditions. Project Narrative
The nuclear receptors we are studying are associated with many disease processes, including cancer, infertility, genetic metabolic diseases, and mental health defects. Learning the mechanisms of action of these receptors, and what goes wrong in the diseases, will help suggest pathways for design of new drug treatments for these conditions.
描述(由申请人提供):核受体程序对健康和生命至关重要的许多内分泌过程。其中最神秘的是那些受体,它们非常重要,但具有未知的调节激素,如DAX-1,LRH-1和SF-1。这就是这项建议的目标。医学疾病告诉我们这些受体在内分泌系统中的相互作用,但没有告诉我们它们的机制。DAX-1基因编码一种不寻常的核受体,缺乏DNA相互作用结构域。然而,它控制着许多组织中许多靶基因的活性。DAX-1的突变影响胚胎干细胞的进展、肾上腺和脑垂体、下丘脑和卵巢或睾丸的发育,导致严重的内分泌失调。受体LRH-1和SF-1在发育过程中至关重要,它们的组成性激活被DAX-1抑制。这三种核受体和转录因子被称为孤儿,因为它们的控制激素,如果它们存在的话,还没有被确定。这些相关的核受体的调节机制的最基本的细节是未知的。
该提案的目标是了解DAX-1调节LRH-1和SF-1的机制的原理和原子水平细节。由于DAX-1抑制转录激活,因此它可能被归类为未知激素的共阻遏物。由于DAX-1的调节依赖于这些蛋白质的结合,我们将以原子分辨率分析DAX-1与LRH-1和SF-1的结合相互作用。DAX-1蛋白质从未被制备成功能活性状态用于生物化学或结构研究,将与LRH-1和SF-1分离和结晶,以便可以分析组装体的三维结构。由结构模型指导的功能研究将在细胞中进行,以揭示这些受体的作用机制。这些信息将是理解许多人类内分泌综合征的分子病理学的基础,并为治疗干预提供建议。
我们正在研究的核受体与许多疾病过程有关,包括癌症,不孕症,遗传代谢疾病和精神健康缺陷。了解这些受体的作用机制,以及疾病中出现的问题,将有助于为这些疾病的新药治疗设计提供途径。项目叙述
我们正在研究的核受体与许多疾病过程有关,包括癌症,不孕症,遗传代谢疾病和精神健康缺陷。了解这些受体的作用机制,以及疾病中出现的问题,将有助于为这些疾病的新药治疗设计提供途径。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
NR5A2 discovering compounds that block tumor growth in PDAC.
- DOI:10.1002/jso.24639
- 发表时间:2017-07
- 期刊:
- 影响因子:2.5
- 作者:Fletterick R
- 通讯作者:Fletterick R
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT J FLETTERICK其他文献
ROBERT J FLETTERICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT J FLETTERICK', 18)}}的其他基金
Screening for antagonists of nuclear receptor LRH-1 in pancreatic cancer cells
胰腺癌细胞核受体LRH-1拮抗剂的筛选
- 批准号:
8411586 - 财政年份:2012
- 资助金额:
$ 33.59万 - 项目类别:
Screening for antagonists of nuclear receptor LRH-1 in pancreatic cancer cells
胰腺癌细胞核受体LRH-1拮抗剂的筛选
- 批准号:
8260928 - 财政年份:2012
- 资助金额:
$ 33.59万 - 项目类别:
Structures of Protein Complexes Regulating Transcription in Enbryonic Stem Cells
调节胚胎干细胞转录的蛋白质复合物的结构
- 批准号:
8502698 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
Structures of Protein Complexes Regulating Transcription in Enbryonic Stem Cells
调节胚胎干细胞转录的蛋白质复合物的结构
- 批准号:
8302340 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
Structures of Protein Complexes Regulating Transcription in Enbryonic Stem Cells
调节胚胎干细胞转录的蛋白质复合物的结构
- 批准号:
8690904 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
Structures of Protein Complexes Regulating Transcription in Enbryonic Stem Cells
调节胚胎干细胞转录的蛋白质复合物的结构
- 批准号:
8149856 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
Consortia for High-Throughput-Enabled Structural Biology Partnerships (U01)
高通量结构生物学合作联盟 (U01)
- 批准号:
8153358 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别:
Structures of Protein Complexes Regulating Transcription in Enbryonic Stem Cells
调节胚胎干细胞转录的蛋白质复合物的结构
- 批准号:
8533829 - 财政年份:2010
- 资助金额:
$ 33.59万 - 项目类别: